Updates on Device-Based Therapies for Patients with Heart Failure

被引：9
作者：
Al Danaf J. [1 ]
Butler J. [2 ]
Yehya A. [3 ]
机构：
[1] Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah, 30 N. 1900E, Room 4A100, Salt Lake City, 84112, UT
[2] Division of Cardiovascular Medicine, Department of Internal Medicine, University of Mississippi, 2500 N State Street L650, Jackson, 39216, MS
[3] Division of Cardiovascular Medicine, Department of Internal Medicine, Augusta University, 95 Collier Rd Suite 3000, Atlanta, 30309, GA
来源：
Current Heart Failure Reports | 2018年 / 15卷 / 2期
基金：
美国国家卫生研究院;
关键词：
Clinical trials; CRT-D; Device-based therapies; Heart failure reduced ejection fraction; Hemodynamic monitoring; LVAD;
D O I：
10.1007/s11897-018-0384-x
中图分类号：
学科分类号：
摘要：
Purpose of Review: Heart failure is a growing epidemic. Optimal medical therapy remains the cornerstone of heart failure management but device-based therapies have been shown to contribute to morbidity and mortality reduction. Recent Findings: Multiple investigational trials had been conducted in the past decade that helped us better understand and manage heart failure. In this manuscript, we will discuss the major device related trials of year 2017 in the fields of defibrillators, hemodynamic monitoring, remote monitoring, autonomic nervous system modulation, ventricular assist devices, and device-based valvular heart disease management. Summary: Further research and trials in device-based therapies are needed to explore their long-term reduction in mortality and morbidity along with cost-effectiveness analyses in patients living with heart failure. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码：53 / 60
页数：7
相关论文
共 56 条
[11]  
Dunlay S.M., Shah N.D., Shi Q., Morlan B., VanHouten H., Long K.H., Et al., Lifetime costs of medical care after heart failure diagnosis, Circ Cardiovasc Qual Outcomes, 4, pp. 68-75, (2011)
[12]  
Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E., Drazner M.H., Et al., 2013 ACCF/AHA guideline for the management of heart failure, J Am Coll Cardiol, 62, 16, pp. e147-e239, (2013)
[13]  
Al-Khatib S.M., Stevenson W.G., Ackerman M.J., Bryant W.J., Callans D.J., Curtis A.B., Et al., 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A report of the American College of Cardiology / American Heart Association Task force on clinical practice guidelines and the Heart Rhythm Society, Circulation
[14]  
Santharam S., Hudsmith L., Thorne S., Clift P., Marshall H., De Bono J., Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes, Europace, 19, pp. 407-413, (2017)
[15]  
Vakil K., Duval S., Cogswell R., Eckman P., Levy W.C., Anand I., Et al., Impact of implantable cardioverter-defibrillators on waitlist mortality among patients awaiting heart transplantation: an UNOS/OPTN analysis, JACC Clin Electrophysiol, 3, pp. 33-40, (2017)
[16]  
Kusumoto F.M., Bailey K.R., Chaouki A.S., Deshmukh A.J., Gautman S., Kim R.J., Et al., Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society [published online ahead of print October 30, 2017, Circulation, (2017)
[17]  
Zeilter E.P., Friedman D.J., Daubert J.P., Al-Khatib S.M., Solomon S.D., Biton Y., Et al., Multiple comorbidities and response to cardiac resynchronization therapy: MADIT-CRT long-term follow-up, J Am Coll Cardiol, 69, 19, pp. 2369-2379, (2017)
[18]  
Daimee U.A., Biton Y., Aktas M.K., Zannad F., Klein H., Szepietowska B., Et al., Effect of significant weight change on inappropriate implantable cardioverter-defibrillator therapy, Pacing Clin Electrophysiol, 40, 1, pp. 9-16, (2017)
[19]  
Skaf S., Thibault B., Khairy P., O'Meara E., Fortier A., Vakulenko H.V., Et al., Impact of left ventricular vs biventricular pacing on reverse remodeling: Insights from the evaluation of resynchronization therapy for heart failure (EARTH) trial, Can J Cardiol, 33, 10, pp. 1274-1282, (2017)
[20]  
Vidula H., Kutyifa V., McNitt S., Goldenberg J., Solomon S.D., Moss A.J., Et al., Long-term survival of patients with left bundle branch bock who are hypo-responders to cardiac resynchronization therapy, Am J Cardiol, 120, 5, pp. 825-830, (2017)
123456